Welcome to our dedicated page for Adapthealth SEC filings (Ticker: AHCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Medicare reimbursement swings, rapid acquisitions, and intricate lease accounting make AdaptHealth Corp’s disclosures some of the most difficult in the home-health sector. If you have ever tried to locate segment revenue shifts or pinpoint when executives sell shares, you know the challenge of AdaptHealth SEC filings explained simply.
Stock Titan solves that complexity. Our AI reads each AdaptHealth annual report 10-K simplified and every AdaptHealth quarterly earnings report 10-Q filing the instant it hits EDGAR, highlighting reimbursement exposure, acquisition earn-outs, and goodwill adjustments. Real-time alerts surface AdaptHealth Form 4 insider transactions real-time, so you never miss crucial AdaptHealth executive stock transactions Form 4. Need headline context? Our platform turns dense 8-Ks into one-screen briefs—think “AdaptHealth 8-K material events explained”—while proxy digests spotlight AdaptHealth proxy statement executive compensation in clear terms.
Use cases span the entire investment workflow:
- Monitor AdaptHealth insider trading Form 4 transactions before major announcements.
- Run comparative AdaptHealth earnings report filing analysis across quarters without slogging through PDFs.
- Speed-read footnotes by understanding AdaptHealth SEC documents with AI—lease liabilities, DSO trends, and integration costs surfaced automatically.
Whether you’re tracking oxygen equipment margins or gauging cash-flow impact from new payer contracts, Stock Titan provides comprehensive coverage of every 10-K, 10-Q, 8-K, S-4, and Form 4—updated in real time and distilled into investor-ready language. Complex filings, clarified.
AdaptHealth Corp (AHCO) filed a Form 3 Initial Statement of Beneficial Ownership for Daniel Edward McFadden, who has been appointed as the company's Chief Business Systems Officer. The filing, dated June 28, 2025, discloses McFadden's initial beneficial ownership position in the company.
Key ownership details:
- McFadden beneficially owns 53,958 shares of common stock in the form of restricted stock units (RSUs)
- The ownership is held directly (D)
- The RSUs will be settled in common stock upon vesting
The filing was executed by Richard Rew as attorney-in-fact for Daniel McFadden on June 26, 2025. This Form 3 filing is required under Section 16(a) of the Securities Exchange Act of 1934 for new officers, directors, or beneficial owners of more than 10% of a company's securities.
AdaptHealth Corp (NASDAQ: AHCO) has filed Amendment No. 1 to its 2024 Annual Report (Form 10-K/A) to address an omission in the original filing regarding equity compensation plan information. The amendment specifically updates Part III, Item 12 to include the previously omitted Equity Compensation Plan Table.
Key equity compensation details as of December 31, 2024:
- 5,115,684 securities to be issued under the A&R 2019 Stock Incentive Plan with weighted-average exercise price of $9.67
- 9,138,317 securities remaining available for future issuance under the A&R 2019 Plan
- 622,398 shares available under the 2019 Employee Stock Purchase Plan
- 782,991 securities granted to CEO Suzanne Foster as employment inducement outside the approved plans
The company is classified as a large accelerated filer with a market value of approximately $1.07 billion for non-affiliate shares as of June 28, 2024. As of February 21, 2025, AdaptHealth had 134,867,011 shares of Common Stock outstanding.
FAQ
What is the current stock price of Adapthealth (AHCO)?
What is the market cap of Adapthealth (AHCO)?
What core services does AdaptHealth Corp provide?
Which patient populations does the company focus on?
How does AdaptHealth ensure the quality of its products and services?
What differentiates AdaptHealth from other home healthcare providers?
How does the company support patients with respiratory conditions?
What role does clinical support play in AdaptHealth's operations?
How does AdaptHealth contribute to the home healthcare industry?
Are the services offered by AdaptHealth comprehensive enough for chronic care management?
